Medical
Lawrence Tallon Named MHRA CEO
Lawrence Tallon has been appointed as the new Chief Executive Officer of the Medicines and Healthcare products Regulatory Agency (MHRA),...
Read moreDetailsDr. Penelope Dash: New NHS England Chair
Dr. Penelope Dash has been appointed as the new Chair of NHS England, effective April 1, 2025, marking a pivotal...
Read moreDetailsNuffield Health Partnership: Free NHS Staff Rehabilitation Program
The UK government has partnered with Nuffield Health to offer a free rehabilitation program for NHS staff suffering from chronic...
Read moreDetailsmRESVIA Vaccine Approval: Protecting Older Adults
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the mRNA-based RSV vaccine, mRESVIA, for individuals aged 60 and...
Read moreDetailsNorovirus Warning: UKHSA Alerts Second Wave
The UK Health Security Agency (UKHSA) has issued a warning about a potential second wave of norovirus infections in the...
Read moreDetailsUK Government Invests £126 Million in Hospice Care
The UK government has announced a substantial investment in hospice care across England, allocating £26 million for children's hospices and...
Read moreDetailsUrgent Dental Appointments: UK Government’s Vital Initiative
The UK government has unveiled plans to offer 700,000 additional urgent dental appointments across England, targeting "dental deserts" where NHS...
Read moreDetailsYouth Vaping Study: Landmark 10-Year Research Initiative
A landmark 10-year study has been launched in the UK to explore the long-term health effects of vaping on young...
Read moreDetailsUK Government Delivers 2 Million NHS Appointments
The UK government has successfully delivered over two million additional NHS appointments ahead of schedule, including critical treatments such as...
Read moreDetailsAltuvoct Approval: Managing Haemophilia A Bleeding
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved efanesoctocog alfa, marketed as Altuvoct, for the prevention and treatment...
Read moreDetails